x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Antibody-based pharmaceuticals resource

Creative Biolabs

Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.

science life sciences

All Episodes

00:15:08

An Overview of Pancreatic Cancer

Antibody-based pharmaceuticals resource ·

2021/12/02

Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration, and low surgical resection rate in the digestive system. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to pancreatic cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related

en

00:08:56

An Overview of Endometrial Cancer

Antibody-based pharmaceuticals resource ·

2021/12/02

Endometrial cancer is the most common female genital cancer in the developed world. In the United States of America, an estimated 2.8% of women will be diagnosed with this malignancy at some point in their lifetime. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for endometrial cancer. In the episode, we will give you a comprehensive introduction to endometrial cancer and

en

00:07:57

An Overview of Thyroid Cancer

Antibody-based pharmaceuticals resource ·

2021/12/02

Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality have increased steadily over the last four decades. Thyroid cancer is commonly diagnosed at a younger age than most other adult cancers. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for thyroid cancer. In the episode, we will give you a comprehensive introduction to

en

00:05:37

Introduction to Motivations for Next-generation ADCs

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column.This is a 10-minute conversation about motivations for next-generation ADCs. If you are interested in ADC-related services, please follow us.

en

00:10:15

Next Generation Payloads for ADCs

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about next generation payloads for ADCs. If you are interested in ADC-related services, please follow us.

en

00:15:03

Combining ADCs with Immuno-oncology

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about combining ADCs with immuno oncology. If you are interested in ADC-related services, please follow us.

en

00:11:26

Delivering More Payload—High DAR ADCs

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. In this episode, we will explore strategies for developing higher DAR ADCs. If you want to know more about our payload technology, please follow us.

en

00:14:39

Site-specific Antibody-drug Conjugates

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about site-specific antibody-drug conjugates. If you are interested in ADC-related services, please follow us.

en

00:14:53

Bispecific and Biparatopic Antibody-drug Conjugates

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about bispecific and biparatopic ADCs. If you are interested in ADC-related services, please follow us.

en

00:14:47

Targeting Drug Conjugates to the Tumor...

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. Today, we are talking about probody drug conjugates, a drug targeting conjugate to the tumor microenvironment. If you want to learn more information about ADC, please follow us.

en

00:11:18

Antibody Drug Conjugates Targeting the Tumor...

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about ADCs targeting the tumor microenvironment. If you are interested in tumor targeting ADC, please follow us.

en

00:11:42

Next Horizons—ADCs Beyond Oncology

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about ADCs beyond oncology. If you want to learn more about ADC, please follow us.

en

00:09:18

What is ADC?

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode describes the basic knowledge of antibody-drug conjugates, including introduction, structural composition, mechanism of action, toxicity risk, and development trends.

en

00:10:30

A Brief Introduction to Antibody-drug Conjugate

Antibody-based pharmaceuticals resource ·

2021/11/02

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. In this episode, we will illustrate detailed information, such as structure and timeline of antibody-drug conjugate (ADC), mechanism of action of ADC, and approved ADC drugs for marketing.

en

514 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter